Slotwiner D, Varma N, Akar JG, Annas G, Beardsall M, Fogel RI, et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart rhythm off J Heart Rhythm Soc. 2015;12(7):e69-100. https://doi.org/10.1016/j.hrthm.2015.05.008.
Akinyele B, Marine JE, Love C, Crawford TC, Chrispin J, Vlay SC, et al. Unregulated online sales of cardiac implantable electronic devices in the United States: a six-month assessment. Heart Rhythm O2. 2020;14:235–8. https://doi.org/10.1016/j.hroo.2020.06.007.
Varma N, Marrouche NF, Aguinaga L, Albert CM, Arbelo E, Choi JI, et al. HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic. Heart rhythm Off J Heart Rhythm Soc. 2020;17(9):e255–68. https://doi.org/10.1016/j.hrthm.2020.06.010.
Burri H, Senouf D. Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators. Europace. 2009;11(6):701–9. https://doi.org/10.1093/europace/eup110.
Burri H. Remote follow-up and continuous remote monitoring, distinguished. Europace. 2013;15(Suppl 1):i14–6. https://doi.org/10.1093/europace/eut071.
Varma N, Love CJ, Michalski J, Epstein AE. Alert-Based ICD Follow-Up JACC: Clinical Electrophysiology. 2021;7(8):976–87. https://doi.org/10.1016/j.jacep.2021.01.008. (This randomized clinical trial illustrates the feasibility and safety of a fully alert-based remote monitoring strategy.
Hindricks G, Varma N, Kacet S, Lewalter T, Sogaard P, Guedon-Moreau L, et al. Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST). Eur Heart J. 2017;38(22):1749–55. https://doi.org/10.1093/eurheartj/ehx015. This meta-analysis shows the potential of remote monitoring to improve rsurvival, mainly by prevention of heart failure exacerbations.
Article PubMed PubMed Central Google Scholar
Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014;384(9943):583–90. https://doi.org/10.1016/S0140-6736(14)61176-4.
Parthiban N, Esterman A, Mahajan R, Twomey DJ, Pathak RK, Lau DH, et al. Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes. J Am Coll Cardiol. 2015;65(24):2591–600. https://doi.org/10.1016/j.jacc.2015.04.029. This meta-analysis demonstrates that the survival benefit associated with remote monitoring is dependent on daily remote transmissions as these allow more rapid clinical event detection.
Varma N, Epstein AE, Irimpen A, Schweikert R, Love C. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up. Circulation. 2010;122(4):325–32. https://doi.org/10.1161/circulationaha.110.937409.
Guedon-Moreau L, Lacroix D, Sadoul N, Clementy J, Kouakam C, Hermida JS, et al. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J. 2013;34(8):605–14. https://doi.org/10.1093/eurheartj/ehs425.
Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation. 2010;122(23):2359–67. https://doi.org/10.1161/CIRCULATIONAHA.110.960633.
Kurek A, Tajstra M, Gadula-Gacek E, Buchta P, Skrzypek M, Pyka L, et al. Impact of remote monitoring on long-term prognosis in heart failure patients in a real-world cohort: results from all-comers COMMIT-HF trial. J Cardiovasc Electrophysiol. 2017;28(4):425–31. https://doi.org/10.1111/jce.13174.
Varma N, Piccini JP, Snell J, Fischer A, Dalal N, Mittal S. The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients. J Am Coll Cardiol. 2015;65(24):2601–10. https://doi.org/10.1016/j.jacc.2015.04.033. In this nationwide analysis on 29471 consecutive patients, the survival benefit associated with remote monitoring was related to patient adherence, but independent of device type.
Mabo P, Victor F, Bazin P, Ahres S, Babuty D, Da Costa A, et al. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J. 2012;33(9):1105–11. https://doi.org/10.1093/eurheartj/ehr419.
Halimi F, Clementy J, Attuel P, Dessenne X, Amara W, Ot Investigators. Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial. Europace. 2008;10(12):1392–9. https://doi.org/10.1093/europace/eun250.
Oliveira M, Fernandes M, Reis H, Primo J, Sanfins V, Silva V, et al. Remote versus in-office monitoring for implantable cardioverter defibrillators: results from a randomized pragmatic controlled study in Portugal. Rev Port Cardiol. 2022. https://doi.org/10.1016/j.repc.2021.08.017.
Article PubMed PubMed Central Google Scholar
Versteeg H, Timmermans I, Widdershoven J, Kimman GJ, Prevot S, Rauwolf T, et al. Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial. Europace. 2019;21(9):1360–8. https://doi.org/10.1093/europace/euz140.
Leppert F, Siebermair J, Wesemann U, Martens E, Sattler SM, Scholz S, et al. The INFluence of Remote monitoring on Anxiety/depRession, quality of lifE, and Device acceptance in ICD patients: a prospective, randomized, controlled, single-center trial. Clin Res Cardiol. 2021;110(6):789–800. https://doi.org/10.1007/s00392-020-01667-0.
Petersen HH, Larsen MC, Nielsen OW, Kensing F, Svendsen JH. Patient satisfaction and suggestions for improvement of remote ICD monitoring. J Interv Card Electrophysiol. 2012;34(3):317–24. https://doi.org/10.1007/s10840-012-9675-4.
Ricci RP, Morichelli L, Quarta L, Sassi A, Porfili A, Laudadio MT, et al. Long-term patient acceptance of and satisfaction with implanted device remote monitoring. Europace. 2010;12(5):674–9. https://doi.org/10.1093/europace/euq046.
Timmermans I, Meine M, Szendey I, Aring J, Romero Roldan J, van Erven L, et al. Remote monitoring of implantable cardioverter defibrillators: patient experiences and preferences for follow-up. Pacing Clinical Electrophysiol. 2019;42(2):120–9. https://doi.org/10.1111/pace.13574.
Artico J, Zecchin M, Zorzin Fantasia A, Skerl G, Ortis B, Franco S, et al. Long-term patient satisfaction with implanted device remote monitoring: a comparison among different systems. J Cardiovasc Med (Hagerstown). 2019;20(8):542–50. https://doi.org/10.2459/JCM.0000000000000818.
Hwang YM, Kim JH. The first survey on patient needs for remote monitoring of cardiac implantable electronic device in South Korea. Medicine (Baltimore). 2022;101(23):e29414. https://doi.org/10.1097/MD.0000000000029414.
Heidbuchel H, Lioen P, Foulon S, Huybrechts W, Ector J, Willems R, et al. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator. Europace. 2008;10(3):351–7. https://doi.org/10.1093/europace/eun010.
Varma N, Pavri BB, Stambler B, Michalski J, Investigators T. Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems. Europace. 2013;15(5):697–703. https://doi.org/10.1093/europace/eus410.
Varma N, Michalski J, Epstein AE, Schweikert R. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance. Circulation: Arrhythmia and Electrophysiology. 2010;3(5):428–36. https://doi.org/10.1161/circep.110.951962.
Varma N. Remote monitoring for advisories: automatic early detection of silent lead failure. Pacing and clinical electrophysiology : PACE. 2009;32(4):525–7. https://doi.org/10.1111/j.1540-8159.2009.02314.x.
Spencker S, Coban N, Koch L, Schirdewan A, Muller D. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace. 2009;11(4):483–8. https://doi.org/10.1093/europace/eun350.
Varma N, Epstein AE, Schweikert R, Michalski J, Love CJ, Investigators T. Role of automatic wireless remote monitoring immediately following ICD implant: the Lumos-T reduces routine office device follow-up study (TRUST) trial. J Cardiovasc Electrophysiol. 2016;27(3):321–6. https://doi.org/10.1111/jce.12895.
Ricci RP, Morichelli L, D’Onofrio A, Calo L, Vaccari D, Zanotto G, et al. Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry. Europace. 2013;15(7):970–7. https://doi.org/10.1093/europace/eus440.
Guedon-Moreau L, Kouakam C, Klug D, Marquie C, Brigadeau F, Boule S, et al. Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial. J Cardiovasc Electrophysiol. 2014;25(7):763–70. https://doi.org/10.1111/jce.12405.
Ricci RP, Pignalberi C, Landolina M, Santini M, Lunati M, Boriani G, et al. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators. Heart. 2014;100(11):848–54. https://doi.org/10.1136/heartjnl-2013-305259.
Varma N, Love CJ, Schweikert R, Moll P, Michalski J, Epstein AE, et al. Automatic remote monitoring utilizing daily transmissions: transmission reliability and implantable cardioverter defibrillator battery longevity in the TRUST trial. Europace. 2018;20(4):622–8. https://doi.org/10.1093/europace/eux059.
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42(35):3427–520. https://doi.org/10.1093/eurheartj/ehab364.
Comments (0)